Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Cells · 18.03.2023 · 12 (6) · 930
DOI: 10.3390/cells12060930 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 18.03.2023. Verfasst von Rita Silva-Pedrosa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal. Hauptthemen laut MEDLINE: Organoids, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 299 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology (FCT).
Abstract (Originalsprache)
Cellular models have created opportunities to explore the characteristics of human diseases through well-established protocols, while avoiding the ethical restrictions associated with post-mortem studies and the costs associated with researching animal models. The capability of cell reprogramming, such as induced pluripotent stem cells (iPSCs) technology, solved the complications associated with human embryonic stem cells (hESC) usage. Moreover, iPSCs made significant contributions for human medicine, such as in diagnosis, therapeutic and regenerative medicine. The two-dimensional (2D) models allowed for monolayer cellular culture in vitro; however, they were surpassed by the three-dimensional (3D) cell culture system. The 3D cell culture provides higher cell–cell contact and a multi-layered cell culture, which more closely respects cellular morphology and polarity. It is more tightly able to resemble conditions in vivo and a closer approach to the architecture of human tissues, such as human organoids. Organoids are 3D cellular structures that mimic the architecture and function of native tissues. They are generated in vitro from stem cells or differentiated cells, such as epithelial or neural cells, and are used to study organ development, disease modeling, and drug discovery. Organoids have become a powerful tool for understanding the cellular and molecular mechanisms underlying human physiology, providing new insights into the pathogenesis of cancer, metabolic diseases, and brain disorders. Although organoid technology is up-and-coming, it also has some limitations that require improvements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal.
- ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.
- Centre of Biological Engineering (CEB), Department of Biological Engineering, University of Minho, 4710-057 Braga, Portugal.
Förderung
- Foundation for Science and Technology (FCT)
Zitieren
APA
Silva-Pedrosa, R., Salgado, A. J., & Ferreira, P. E. (2023). Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems. Cells, 12(6), 930. https://doi.org/10.3390/cells12060930
Vancouver
Silva-Pedrosa R, Salgado AJ, Ferreira PE. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems. Cells. 2023;12(6):930. doi:10.3390/cells12060930
BibTeX
@article{SilvaPedrosa2023,
author = {Silva-Pedrosa, Rita and Salgado, António José and Ferreira, Pedro Eduardo},
title = {Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems},
journal = {Cells},
year = {2023},
volume = {12},
number = {6},
pages = {930},
doi = {10.3390/cells12060930}
}
EUVIMED